INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 108 filers reported holding INSMED INC in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $545 | -100.0% | 27,300 | -25.2% | 0.00% | 0.0% |
| Q4 2017 | $1,138,000 | -34.7% | 36,487 | -34.7% | 0.00% | -50.0% |
| Q3 2017 | $1,744,000 | +9.4% | 55,887 | -53.6% | 0.00% | -33.3% |
| Q4 2016 | $1,594,000 | -44.5% | 120,500 | -39.0% | 0.00% | -40.0% |
| Q3 2016 | $2,871,000 | +95.0% | 197,700 | +32.4% | 0.01% | +66.7% |
| Q2 2016 | $1,472,000 | -36.8% | 149,300 | -18.8% | 0.00% | -25.0% |
| Q1 2016 | $2,329,000 | +139.9% | 183,787 | +278.3% | 0.00% | +100.0% |
| Q2 2014 | $971,000 | – | 48,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |